Scott M. Rocklage, PhD is the Founding Partner of 5AM Venture Management LLC. He had previously served as Managing Partner, a role he assumed in 2004.
He has had a long time career in healthcare leadership and previously served as Chairman and CEO of Cubist Pharmaceuticals. His career spans over 30 years. Prior to his employment at Cubist, Dr. Rocklage held the positions of President and CEO of Nycomed Salutar, and more. Under his leadership, three new drugs were approved by the US FDA. In 2003, he started at 5AM Venture.
Dr. Scott Rocklage graduated from the University of California in Berkeley, having achieved his Bachelor of Science degree in chemistry. He went on to the Massachusetts Institute of Technology, at which he earned his PhD. Dr. Rocklage has received 30 patents, from his own inventions and with others as co-inventors.
He works out of the Boston, MA office. 5AM Venture Management is a capital management firm that focuses on early stage, startup drug development companie. Amongst these, they seek out companies in the specialized areas of drug development for anti infection and diabetes, as well as treatment for metabolic diseases, and oncology.
Under the leadership of Dr. Scott Rocklage, it will select companies to invest in, that meet its criteria. The company will be the main initial investor, for companies located in the United States and Switzerland. It is headquartered in San Francisco, California, and also has an office in Massachusetts.
Dr. Rocklage, with his years of experience, has grown the company tremendously during his 15 year tenure with them. 5AM Venture Management hosts many global forums, of which the next upcoming forum is the Biocom’s Global Life Science Partnering Conference 2018. It will be held in La Jolla, California.
Connect with Dr. Scott Rocklage on LinkedIn.